BioCentury | Mar 24, 1997
Clinical News

Watson regulatory update

...Oclassen Pharmaceuticals Inc. subsidiary (San Rafael, Calif.) received FDA marketing approval for Condylox Gel 0.5 percent (podofilox...
...Condylox Topical Solution 0.5 percent in 1991, reaching sales of about $10 million in 1996. Condylox Gel...
BioCentury | Sep 11, 1995
Company News

Oclassen Pharmaceuticals Inc., Healthpoint Medical deal

...it licensed the products to concentrate on its core business in dermatology, which includes Condylox (podofilox...
BioCentury | Jan 16, 1995
Company News

Oclassen Pharmaceuticals Inc. deal

...Bock Pharmacal Co.'s 240-person sales force will handle all promotional activities for Oclassen’s Condylox (podofilox) genital...
BioCentury | Jan 10, 1994
Company News

Oclassen Pharmaceuticals Inc. deal

...wound care products developed by Perstorp. Perstorp will manufacture the product. Separately, Oclassen said that podofilox...
Items per page:
1 - 4 of 4